Chart Industries, Inc. (GTLS)
NYSE: GTLS · Real-Time Price · USD
198.96
+0.23 (0.12%)
At close: Aug 12, 2025, 4:00 PM
198.96
0.00 (0.00%)
After-hours: Aug 12, 2025, 7:00 PM EDT

Blueprint Medicines Revenue

Chart Industries had revenue of $1.08B in the quarter ending June 30, 2025, with 4.04% growth. This brings the company's revenue in the last twelve months to $4.25B, up 8.94% year-over-year. In the year 2024, Chart Industries had annual revenue of $4.16B with 24.10% growth.

Revenue (ttm)
$4.25B
Revenue Growth
+8.94%
P/S Ratio
2.04
Revenue / Employee
$356,564
Employees
11,928
Market Cap
8.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20244.16B807.80M24.10%
Dec 31, 20233.35B1.74B107.92%
Dec 31, 20221.61B294.70M22.36%
Dec 31, 20211.32B140.60M11.94%
Dec 31, 20201.18B-38.40M-3.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition